EG00229
Based on 12 publication(s) in Google Scholar
EG00229 is an inhibitor for VEGF-A and NRP1 interaction with an IC50 of 8 μM. EG00229 inhibits the migration of HUVECS and the phosphorylation of VEGFR2 in endothelial cells. EG00229 exhibits cytotoxicity in cancer cell A549.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1018927-63-3
- Formel: C17H19N7O5S3
- Molecular Weight:497.57
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) EG00229
More- EBioMedicine. 2019 May:43:525-536. [Abstract]
- Acta Pharmacol Sin. 2026 Feb 19. [Abstract]
- Proc Natl Acad Sci U S A. 2026 Mar 31;123(13):e2510265123. [Abstract]
- Mol Med. 2025 Dec 16;31(1):336. [Abstract]
- Fluids Barriers CNS. 2024 Apr 8;21(1):32. [Abstract]
- Biochem Pharmacol. 2026 Jun 12;251(Pt 2):118163. [Abstract]
- Biochem Pharmacol. 2025 Nov:241:117183. [Abstract]
- Biochem Pharmacol. 2022 May;199:115030. [Abstract]
- Bioorg Med Chem. 2020 Jan 1;28(1):115183. [Abstract]
- J Cancer. 2021 Aug 24;12(20):6105-6117. [Abstract]
- Cell Physiol Biochem. 2017;44(3):1251-1262. [Abstract]
- bioRxiv. 2024 Oct 21:2023.12.06.570398. [Abstract]
-
WB
-
Cell Imaging/Staining
-
In Vivo Efficacy Study
-
Cell Proliferation/Viability Assay
-
RT-PCR
Alle VEGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
7 μM
Compound: 2, EG00229
|
Displacement of [125I]VEGF-A from human NRP1 expressed in human A549 cells
Displacement of [125I]VEGF-A from human NRP1 expressed in human A549 cells
|
[PMID: 20151671] |
| DU-145 | IC50 |
3 μM
Compound: 2, EG00229
|
Displacement of biotinylated-VEGF-A125 from human NRP1 expressed in human DU145 cells
Displacement of biotinylated-VEGF-A125 from human NRP1 expressed in human DU145 cells
|
[PMID: 20151671] |
| HEK293 | IC50 |
11.1 μM
Compound: EG00229
|
Inhibition of recombinant human biotinylated VEGF-165A expressed in HEK293 cells binding to immobilized recombinant full length human FC-tagged NRP1 (chimera active) expressed in HEK293 cells using TMB as substrate incubated for 2 hrs followed by substrat
Inhibition of recombinant human biotinylated VEGF-165A expressed in HEK293 cells binding to immobilized recombinant full length human FC-tagged NRP1 (chimera active) expressed in HEK293 cells using TMB as substrate incubated for 2 hrs followed by substrat
|
[PMID: 31744780] |
| HUVEC | IC50 |
23 μM
Compound: 2, EG00229
|
Displacement of biotinylated-VEGF-A125 from human NRP1 expressed in HUVEC
Displacement of biotinylated-VEGF-A125 from human NRP1 expressed in HUVEC
|
[PMID: 20151671] |
Chemical Information
-
CAS. Nr. 1018927-63-3
-
Molecular Weight 497.57
-
Formel C17H19N7O5S3
-
SMILES
N=C(N)NCCC[C@@H](C(O)=O)NC(C1=C(NS(=O)(C2=CC=CC3=NSN=C32)=O)C=CS1)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
EBioMedicine
Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. [Abstract]2019 May:43:525-536. PMID: 31060904
EG00229 purchased from MedChemExpress. Usage Cited in: EBioMedicine. 2019 May:43:525-536. [Abstract]
EG00229 trifluoroacetate (NRP-1 inhibitor) (10-50 μM; once daily for 7 d) concentration-dependently increased the survival rate of fibrotic liver tissues from patients.
EG00229 purchased from MedChemExpress. Usage Cited in: EBioMedicine. 2019 May:43:525-536. [Abstract]
EG00229 trifluoroacetate (NRP-1 inhibitor) (10-50 μM; once daily for 7 d) significantly decreased the mRNA levels of CD31, α-SMA, collagen1α I, and FN in fibrotic liver tissues from patients.
-
Acta Pharmacol Sin
Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1. [Abstract]2026 Feb 19. PMID: 41714725 -
Proc Natl Acad Sci U S A
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. [Abstract]2026 Mar 31;123(13):e2510265123. PMID: 41886374
EG00229 purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2026 Mar 31;123(13):e2510265123. [Abstract]
NRP1 inhibitor EG00229 (10-100 μM) blocked ANGPTL4-induced RAD51 phosphorylation in Tyr315 and Tyr54 of NOKSI cells.
EG00229 purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2026 Mar 31;123(13):e2510265123. [Abstract]
EG00229 trifluoroacetate (NRPi) (10-50 µM; 48 h) led to an increase in the DDR in CAL27 cells.
EG00229 purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2026 Mar 31;123(13):e2510265123. [Abstract]
EG00229 trifluoroacetate (NRPi) (10 mg/kg; i.p.) sensitized CAL27 xenografts mice to a subtherapeutic dose of cisplatin (5 mg/kg) markedly reducing tumor volume respectively.
-
Mol Med
Epigenetic reprogramming drives endothelial dysfunction via neuropilin-1 in pulmonary hypertension. [Abstract]2025 Dec 16;31(1):336. PMID: 41402732 -
Fluids Barriers CNS
SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway. [Abstract]2024 Apr 8;21(1):32. PMID: 38584257 -
Biochem Pharmacol
Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen. [Abstract]2026 Jun 12;251(Pt 2):118163. PMID: 42285368 -
Biochem Pharmacol
Pitavastatin overcomes multi-drug resistance in CRC and NSCLC by targeting the NRP1-ZFX axis. [Abstract]2025 Nov:241:117183. PMID: 40684995 -
Biochem Pharmacol
Tuftsin ameliorates splenic inflammatory injury by promoting neuropilin-1 in severe acute pancreatitis. [Abstract]2022 May;199:115030. PMID: 35381211 -
Bioorg Med Chem
Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification. [Abstract]2020 Jan 1;28(1):115183. PMID: 31744780 -
J Cancer
2021 Aug 24;12(20):6105-6117. PMID: 34539883 -
Cell Physiol Biochem
VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells. [Abstract]2017;44(3):1251-1262. PMID: 29179185
EG00229 purchased from MedChemExpress. Usage Cited in: Cell Physiol Biochem. 2017;44(3):1251-1262. [Abstract]
The inhibitor of NRP-1 called EG00229 decreases sphere and clone formation in MDA-MB-231 cells.
-
bioRxiv
2024 Oct 21:2023.12.06.570398. PMID: 38106002
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)